Trial intelligence / Profile preview

HYDRATE-PFA

NCT07490808Completed

Sponsor
Beijing An Zhen Hospital
Start
Mar 2026
Primary completion
Jul 2026
Countries
1
01

Overview

Randomised, open-label trial of sodium chloride in acute kidney injury (AKI) (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: In-hospital acute kidney injury. Started Mar 2026; status: completed.

02

Drugs

sodium chloride
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT07490808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07490808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call